Loading provider…
Loading provider…
Ophthalmology Physician in Houston, TX
NPI: 1003914151Primary Practice Location
HOUSTON METHODIST HOSPITAL
6565 Fannin St, Houston, TX
Primary Employer
Retina Consultants of Houston PLLC
retinaconsultantstexas.com
HQ Phone
Get M.D. Tien's Phone Numberphone_androidMobile
Get M.D. Tien's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1988 - 2025
LA State Medical License
1997 - 2007
PA State Medical License
1988 - 1998
NJ State Medical License
1989 - 1997

American Board of Ophthalmology
Ophthalmology
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
Residency • Ophthalmology
1988 - 1991
Baylor College Of Medicine
bcm.edu
Internship • Transitional Year
1987 - 1988
Medical School
Until 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 815 | 2,491 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 695 | 1,390 |
| 3 | 67028Injection of drug into eye | 412 | 1,875 |
| 4 | J0178Injection, aflibercept, 1 mg | 312 | 3,440 |
| 5 | J3590Unclassified biologics | 177 | 384 |
Prostaglandin-Induced Macular Hole: A Brief Report.
Authors: Patricia Chevez-Barrios, Bin Teh, Ryan Kim, Amy Schefler
Journal: Am J Ophthalmol
Publication Date: 2016-11-04
Authors: Charles Wykoff, Ankit Kadakia
Journal: Retina
Lead Sponsor: Charles C Wykoff, PhD, MD
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Aflibercept
Lead Sponsor: Greater Houston Retina Research
Collaborators: Regeneron Pharmaceuticals, The Cleveland Clinic
Intervention / Treatment: DRUG: Aflibercept Injection
Lead Sponsor: Amy C Schefler, MD
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Aflibercept